Filter
1630
Filtered Results: 1630
Text search:
drug
storage
Featured
Recommendations
172
New Publications
560
Language
Document type
No document type
1008
Guidelines
269
Studies & Reports
150
Manuals
99
Strategic & Response Plan
54
Fact sheets
20
Training Material
19
Situation Updates
7
Brochures
1
Resource Platforms
1
Infographics
1
Online Courses
1
Countries / Regions
India
116
Kenya
69
Ethiopia
55
Uganda
54
Sierra Leone
48
Tanzania
46
Liberia
45
Nigeria
41
Global
33
Nepal
32
Zambia
32
Malawi
31
South Africa
30
Myanmar / Burma
28
Ghana
27
Bangladesh
23
Western and Central Europe
23
Rwanda
21
Namibia
20
Philippines
19
Zimbabwe
18
Africa
13
Cambodia
12
Lesotho
12
Botswana
11
Syria
10
Latin America and the Carribbean
10
Eswatini/ Swaziland
8
Congo, Democratic Republic of
7
Ukraine
7
South–East Asia Region
7
Eastern Europe
7
USA
6
Mozambique
6
Asia
6
Haiti
5
Pakistan
5
Tajikistan
5
Senegal
4
Cameroon
4
Iraq
4
East and Southern Africa
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Russia
4
Burkina Faso
3
South Sudan
3
Afghanistan
3
West and Central Africa
3
Albania
3
Guinea
2
Saudi Arabia
2
Jordan
2
Lebanon
2
Indonesia
2
Papua New Guinea
2
Sudan
2
Argentina
2
Sri Lanka
2
Bhutan
2
Iran
2
Uzbekistan
2
Georgia
2
Morocco
1
Somalia
1
Germany
1
Thailand
1
Gambia
1
Malaysia
1
Benin
1
Central African Republic
1
North Macedonia
1
Honduras
1
El Salvador
1
Greece
1
Libya
1
Madagascar
1
Yemen
1
Western Pacific Region
1
Fiji
1
Palestine
1
Laos
1
Lithuania
1
Moldova
1
Australia
1
Turkmenistan
1
Denmark
1
Maldives
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
798
Clinical Guidelines
169
Public Health
73
Women & Child Health
67
Key Resources
51
Pharmacy & Technologies
50
Capacity Building
19
Toolboxes
Pharmacy
115
TB
105
HIV
94
AMR
81
COVID-19
69
Mental Health
57
NTDs
47
Rapid Response
45
Caregiver
36
Planetary Health
33
Ebola
28
Conflict
25
NCDs
18
Cholera
14
Refugee
13
Natural Hazards
12
Specific Hazards
12
Global Health Education
9
Disability
6
Polio
4
Health Financing Toolbox
3
Zika
2
Social Ethics
1
Agodokpessi et al. Journal of Pharmaceutical Policy and Practice (2015) 8:12DOI 10.1186/s40545-015-0033-7
Benin established a revolving drug fund (RDF) for essential asthma medicines in 2008. We evaluated
the operation of the RDF and assessed wh...
this Service Delivery brief provides evidence-based strategies that can help support drug shops and pharmacies in providing a wider variety of family planning methods and information. Evidence shows that with training and support, pharmacy and ... shop staff can facilitate the use of a broad range of modern contraception, especially in areas where the unmet need is high, access to family planning services is poor, and health worker shortages and other barriers prevent women, men, and youth from accessing family planning services
Availabe in English, French, Spanish and Portuguese
Antimicrobial resistance is a global crisis that threatens a century of progress in health and achievement of the Sustainable Development Goals. There is no time to wait. Unless the world acts urgently, antimicrobial resistance will have disastrous impact within a generation.
2nd edition
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ...
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
An update from the EU Early Warning System
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis.
If no action is taken - warns the UN Ad hoc Interagency Coordin...
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
Available in English, French, Spanish, Russian, Chinese, Arabic and Portugues
EClinicalMedicine 1 (2018) 21–27
https://doi.org/10.1016/j.eclinm.2018.06.005
2589-5370/© 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
EClinicalMedicine: journal homepage: https://www.jo...
Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis: learners’ guide. World Health Organization.
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of ... Resistant TB" (PMDT) refers to programme based MDR TB diagnosis, management and treatment. This guideline promotes full integration of basic TB control and PMDT activities under the NTP, so that patients with TB are evaluated for drug resistance and are placed on the appropriate treatment regimen and properly managed from the outset of treatment, or as early as possible. The guidelines also integrate the identification and treatment of more severe forms of drug resistance, such as extensively drug resistant TB (XDR TB).
At the end, the guideline introduces new standards for registering, monitoring and reporting outcomes of multidrug resistant TB cases.
The term "Programmatic Management of ... Resistant TB" (PMDT) refers to programme based MDR TB diagnosis, management and treatment. This guideline promotes full integration of basic TB control and PMDT activities under the NTP, so that patients with TB are evaluated for drug resistance and are placed on the appropriate treatment regimen and properly managed from the outset of treatment, or as early as possible. The guidelines also integrate the identification and treatment of more severe forms of drug resistance, such as extensively drug resistant TB (XDR TB).
At the end, the guideline introduces new standards for registering, monitoring and reporting outcomes of multidrug resistant TB cases.
